{"disease":{"id":"intestinal-ultrasound","name":"intestinal ultrasound"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05692024","title":"COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07093294","title":"Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07034664","title":"IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT06165029","title":"IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT06573944","title":"IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study","phase":"","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}